A National Briefing: CDC on COVID-19 & Autoimmune Disease
|
|
Friday, April 3, 2020 | 2:00- 3:00 p.m. (Eastern)
|
|
Join us for a one-hour webinar featuring panelists with a profound understanding of COVID-19 and its effects on the autoimmune community. Upon registration, participants will be invited to submit questions for our panelists. We will do our best to field as many questions as possible during and after the webinar.
|
|
Georgina Peacock, MD, MPH, FAAP
Director, Division of Human Development and Disability
Georgina Peacock, MD, MPH, FAAP is the Division Director for the Division of Human Development and Disability (DHDD) at the National Center on Birth Defects and Developmental Disabilities (NCBDDD). Dedicated to the health and development of children and adults across the lifespan, she applies her personal passion and knowledge to a critical leadership position at the Centers for Disease Control and Prevention (CDC).
In her role at DHDD, Dr. Peacock directs CDC’s public health approach, which helps children and adults with disabilities get the most out of life by supporting programs, surveillance, research and policies that facilitate better healthcare, increases in accessibility, and inclusion. DHDD also works to optimize child development for those at risk for high-impact conditions so children can reach their full potential in life. Dr. Peacock oversees a division staff focused on the best health outcomes for the following populations:
- Infants and children with attention-deficit/hyperactivity disorder, fragile X syndrome, hearing loss, autism spectrum disorders, and Tourette Syndrome
- Infants and children at risk for developmental delays, disabilities, and mental disorders
- Adults living with disabilities, including those with intellectual, functional, mobility and cognitive limitations
In addition to her DHDD responsibilities, Dr. Peacock sees patients in developmental clinics – the Good Samaritan Health Center and the DeKalb County Refugee Clinic – while also serving as an adjunct professor with Emory University Department of Pediatrics, the Georgia State Center for Leadership in Disability and the Georgia Leadership & Education in Neurodevelopmental Disabilities program. She also represents CDC on a number of federal and national committees including the HHS Pediatric/Obstetric Integrated Program Team, the HHS CHILD Working Group, the American Academy of Pediatrics (AAP) Council on Children with Disabilities, and AAP’s Disaster Preparedness Advisory Council.
|
|
Nancy Carteron, MD, FACR
Rheumatologist, San Francisco, CA
Nancy Carteron, MD, is a San Francisco area rheumatologist and former Chair of the Medical & Scientific Advisors for the Sjogren's Foundation, with a long-standing interest in Sjögren’s and autoimmune diseases. Dr. Carteron recently joined the University of California, Berkeley, School of Optometry, to collaborate with dry eye and oral medicine specialists to advise Sjögren’s patients. She is also the medical and scientific editor for
Sjögren’s Quarterly
as well as the Rheumatology Chair for the Sjögren’s Foundation Clinical Practice Guidelines initiative. Dr. Careteron has presented around the world on various autoimmune conditions and also co-authored a book,
A Body Out of Balance
, with an autoimmune disease patient.
|
|
Aline Charabaty, MD, AGAF
Clinical Director of the GI Division and
Director of the IBD Center
Johns Hopkins-Sibley Memorial Hospital
Dr. Aline Charabaty is the Clinical Director of the GI Division and Director of the Inflammatory Bowel Diseases (IBD) Center at Johns Hopkins-Sibley Memorial Hospital. She completed her residency and GI fellowship at Georgetown University Hospital, where she joined the GI faculty and established and led the IBD center for 13 years before joining the Johns Hopkins School of Medicine faculty in January 2019. She lectures on IBD at national meetings and has advocated for patients with inflammatory bowel diseases on the Hill. She also uses social media to educate colleagues and IBD patients. She founded @MondayNightIBD, a twitter forum that brings clinicians together to discuss the management of complex IBD cases and received the Healio Gastroenterology Disruptive Innovator Award for that initiative during ACG 2019.
Dr. Charabaty is the Chair of the Greater Washington DC/Virginia Crohns and Colitis Foundation Mission Committee since 2012 and served on the CCF National Scientific Advisory Committee Patient Education and Physician Education Committees. She is actively involved in educational and/or advocacy activities and committees with the American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG). She was selected as a Washingtonian Top Doctors by her peers.
|
|
Dr. Betty Diamond
Chair, AARDA Scientific Advisory Board
Dr. Betty Diamond graduated with a BA from Harvard University and an MD from Harvard Medical School. She performed a residency in internal medicine at Columbia Presbyterian Medical Center and received postdoctoral training in immunology at the Albert Einstein College of Medicine.
Dr. Diamond has headed the rheumatology divisions at Albert Einstein School of Medicine and at Columbia University Medical Center. She also directed the Medical Scientist Training Program at Albert Einstein School of Medicine for many years. She is currently head of the Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases at The Feinstein Institutes for Medical Research and director of the PhD and MD/PhD programs of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.
A former president of the American Association of Immunology, Dr. Diamond has also served on the Board of Directors of the American College of Rheumatology and the Scientific Council of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Dr. Diamond is a fellow of the American Association for the Advancement of Science (AAAS) and a member of the National Academy of Medicine.
|
|
|
|
|
|
|
